SpineGuard SA (EPA:ALSGD)
France · Delayed Price · Currency is EUR 0.0981
-0.0059 (-5.67%)
Sep 11, 2026, 5:35 PM CET
SpineGuard Revenue
SpineGuard had revenue of 1.45M EUR in the half year ending June 30, 2026, a decrease of -40.76%. This brings the company's revenue in the last twelve months to 3.09M, down -28.61% year-over-year. In the year 2025, SpineGuard had annual revenue of 3.76M, down -19.17%.
Revenue (ttm)
3.09M
Revenue Growth
-28.61%
P/S Ratio
2.98
Revenue / Employee
237.41K
Employees
13
Market Cap
9.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.76M | -891.00K | -19.17% |
| Dec 31, 2024 | 4.65M | 335.00K | 7.77% |
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | 4.85M | -1.98M | -28.95% |
| Dec 31, 2019 | 6.83M | -746.48K | -9.85% |
| Dec 31, 2018 | 7.58M | -598.57K | -7.32% |
| Dec 31, 2017 | 8.17M | 710.97K | 9.53% |
| Dec 31, 2016 | 7.46M | 1.12M | 17.60% |
| Dec 31, 2015 | 6.35M | 1.91M | 43.05% |
| Dec 31, 2014 | 4.44M | -178.85K | -3.88% |
| Dec 31, 2013 | 4.62M | 738.04K | 19.04% |
| Dec 31, 2012 | 3.88M | 873.46K | 29.08% |
| Dec 31, 2011 | 3.00M | 322.37K | 12.02% |
| Dec 31, 2010 | 2.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 168.60M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 52.86M |
| Median Technologies | 23.47M |
| Novacyt | 22.96M |
| Implanet | 12.47M |
| Bluelinea Société Anonyme | 11.12M |